Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review

Biologic Therapy and Cardiometabolic Risk in Psoriasis: A Retrospective Review

Abstract Introduction Psoriasis is a systemic inflammatory disease with increased cardiometabolic risk including dyslipidaemia and diabetes. Biologic therapy effectively treats the cutaneous inflammatory burden of psoriasis and evolving evidence suggests potential to reduce systemic inflammatory seq...

Full description

Bibliographic Details
Main Authors: Annika Smith, Aidin Karahasan, Deborah Yi, Sanjay Yapabandara, James Elhindi, Pablo Fernandez-Penas, Clara Chow, Sarah Zaman
Format: Article
Language:English
Published: Adis, Springer Healthcare 2025-01-01
Series:Dermatology and Therapy
Subjects:
Cardiometabolic risk
Biologic therapy
Psoriasis
Cardiovascular disease
Metabolic syndrome
Lipids
Online Access:https://doi.org/10.1007/s13555-024-01327-5

Internet

https://doi.org/10.1007/s13555-024-01327-5

Similar Items